科伦药业:拟分拆科伦博泰至香港联交所上市
国家卫健委印发第二批国家重点监控合理用药药品目录。","multimedia":{"img_url":["https://n.sinaimg.cn/zhibo/324/w365h759/20230113/3ada-c30a8f90ad79fe1c3fad6616a7e81694.png"]},"commentid":"live:finance-152-2943046:0","compere_id":0,"creator":"wangxiang8@staff.sina.com.cn","mender":"wangxiang8@staff.sina.com.cn","create_time":"2023-01-13 20:28:38","update_time":"2023-01-13 20:29:42","is_need_check":"0","check_time":"1970-01-01 08:00:01","check_status":"1","check_user":"","is_delete":0,"top_value":0,"is_focus":0,"source_content_id":"0","anchor_image_url":"","anchor":"直播员","ext":"{"stocks":[],"needPush":false,"needAIPush":false,"needCMSLink":true,"needCalender":false,"needProvince":"0","docurl":"https:\/\/finance.sina.com.cn\/7x24\/2023-01-13\/doc-imyaaarc9087880.shtml","docid":"myaaarc9087880"}","old_live_cid":"0","tab":"","tag":[{"id":"1","name":"宏观"},{"id":"2","name":"行业"}],"like_nums":0,"comment_list":{"list":[],"total":0,"thread_show":0,"qreply":0,"qreply_show":0,"show":0},"docurl":"https://finance.sina.cn/7x24/2023-01-13/detail-imyaaarc9087880.d.html","rich_text_nick_to_url":[],"rich_text_nick_to_routeUri":[],"compere_info":""},{"id":2943045,"zhibo_id":152,"type":0,"rich_text":"【科伦药业:拟分拆科伦博泰至香港联交所上市】科伦药业公告,拟将控股子公司科伦博泰分拆至香港联交所上市。本次分拆完成后,科伦药业股权结构不会发生变化,且仍将保持对科伦博泰的控制权。通过本次分拆,科伦博泰作为公司下属生物创新药研发、生产、上市及国际合作业务的主要平台将实现独立上市。
本文系网络转载,不代表本站立场。